Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 7648142)

Published in Br J Surg on August 01, 1995

Authors

N Scott1, P Jackson, T al-Jaberi, M F Dixon, P Quirke, P J Finan

Author Affiliations

1: Department of Pathology, General Infirmary, Leeds, UK.

Articles citing this

Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection. Surg Endosc (2009) 2.13

Surgical treatment of adenocarcinoma of the rectum. Ann Surg (1998) 1.77

The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis (2003) 1.54

Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol (2010) 1.24

Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol (2011) 1.18

Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis (2004) 0.99

High ligation of the inferior mesenteric artery in rectal cancer surgery. Surg Today (2012) 0.97

Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbecks Arch Surg (2005) 0.90

Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options. World J Gastroenterol (2014) 0.89

Association between a close distal resection margin and recurrence after a sphincter-saving resection for t3 mid- or low-rectal cancer without radiotherapy. Ann Coloproctol (2013) 0.89

Histological processing variability in the determination of lateral resection margins in rectal cancer. J Clin Pathol (2006) 0.88

Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg (2004) 0.88

Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol (2005) 0.88

Total mesorectal excision: technical aspects. Can J Surg (2004) 0.87

Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget (2015) 0.86

Techniques in total mesorectal excision surgery. Clin Colon Rectal Surg (2015) 0.85

Distribution of lymph nodes in the mesorectum: how deep is TME necessary? Tech Coloproctol (2008) 0.82

Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections. World J Gastroenterol (2004) 0.82

Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers. World J Surg Oncol (2010) 0.81

Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer. Surg Today (2013) 0.81

Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003. Int J Colorectal Dis (2004) 0.81

Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases. World J Gastroenterol (2003) 0.81

Total mesorectal excision: what are we doing? Clin Colon Rectal Surg (2007) 0.79

[Anorectal melanoma. A rare and highly malignant tumor entity of the anal canal]. Pathologe (2004) 0.79

Surgical issues in locally advanced rectal cancer treated by preoperative chemoradiotherapy. J Korean Surg Soc (2012) 0.78

Rectal cancer: An evidence-based update for primary care providers. World J Gastroenterol (2015) 0.77

A new sphincter-preserving operation for low rectal cancer: ultralow anterior resection and colorectal/coloanal anastomosis by supporting bundling-up method. Int J Colorectal Dis (2010) 0.77

The extramural metastasis might be categorized in lymph node staging for colorectal cancer. BMC Cancer (2011) 0.76

Changing the Way We Manage Rectal Cancer-Standardizing TME from Open to Robotic (Including Laparoscopic). Clin Colon Rectal Surg (2015) 0.76

Anatomical considerations in TNM staging and therapeutical procedures for low rectal cancer. Int J Colorectal Dis (2007) 0.76

Advances in the management of rectal cancer. J R Soc Med (2002) 0.76

Endoscopically observable white nodule caused by distal intramural lymphatic spread of rectal cancer: a case report. World J Surg Oncol (2012) 0.75

Oncologic outcomes in rectal cancer with close distal resection margins: a retrospective analysis. Ann Surg Treat Res (2015) 0.75

Oncologic Outcomes and Risk Factors for Recurrence after Tumor-specific Mesorectal Excision of Rectal Cancer: 782 Cases. J Korean Soc Coloproctol (2012) 0.75

Colorectal cancer implant in an external hemorrhoidal skin tag. Proc (Bayl Univ Med Cent) (2016) 0.75

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies. World J Gastrointest Surg (2017) 0.75

Effect of extended radical resection for rectal cancer. World J Gastroenterol (2003) 0.75

A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma. J Cancer (2017) 0.75

Management of the pelvic recurrence of rectal cancer with radiofrequency thermoablation: a case report and review of the literature. Int J Colorectal Dis (2004) 0.75

Articles by these authors

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72

Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J Bacteriol (1997) 6.93

Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13

Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut (2008) 5.86

Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36

Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24

Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91

SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet (2001) 3.76

WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73

Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66

Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg (2010) 3.63

Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol (1990) 3.30

Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23

Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell (1989) 3.07

Cost effectiveness of antenatal screening for cystic fibrosis. BMJ (1995) 3.05

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04

Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg (2010) 3.03

The use of vacuum-assisted closure of abdominal wounds: a word of caution. Colorectal Dis (2007) 2.99

Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98

Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg (2012) 2.93

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78

Unlocking the archive--gene expression in paraffin-embedded tissue. J Pathol (2001) 2.76

Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73

Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68

Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60

Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59

Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58

Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem (1983) 2.57

Sequence, assembly and analysis of pX01 and pX02. J Appl Microbiol (1999) 2.53

PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res (1983) 2.41

Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut (1991) 2.35

Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31

Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31

Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27

Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26

Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg (2010) 2.23

An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21

Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21

Follicular stimulation for high tech pregnancies: are we playing it safe? BMJ (1989) 2.18

The sequence and topology of human complement component C9. EMBO J (1985) 2.18

Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17

Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10

Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. BMJ (1989) 2.07

Factors influencing the psychological impact of prolonged unemployment and of re-employment. Psychol Med (1985) 2.03

Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology (2007) 2.01

Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00

PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00

Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99

PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology (1985) 1.97

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94

Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93

Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92

Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92

Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89

Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82

Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem (1983) 1.80

Characterisation of the paxillin-binding site and the C-terminal focal adhesion targeting sequence in vinculin. J Cell Sci (1994) 1.76

The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis (1988) 1.72

Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71

p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70

MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70

Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70

The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69

Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Mol Cell Biol (1991) 1.68

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet (2002) 1.68

Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68

The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68

Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66

Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64

Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics (1994) 1.63

Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62

Methylation and colorectal cancer. J Pathol (2001) 1.61

c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61

Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61

Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60

Identification of a talin binding site in the cytoskeletal protein vinculin. J Cell Biol (1989) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60

Intra-anal collagen injection for the treatment of faecal incontinence. Br J Surg (2006) 1.58

Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58